U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of Nonprescription Drugs - Division of Nonprescription Drugs II
  1. CDER Offices and Divisions

Office of Nonprescription Drugs - Division of Nonprescription Drugs II

The Division of Nonprescription Drugs (DNPD II) reviews and regulates nonprescription products for:

  • Anti-Infectives
  • Antivirals
  • Cardiology and Nephrology
  • Dentistry
  • Diabetes, Lipid Disorders, and Obesity
  • Ophthalmology
  • Otic
  • Urology, Obstetrics, and Gynecology

Director: Pamela Horn, M.D.
Deputy Director: Melanie Blank, M.D.

Deputy Director for Safety: Amy Woitach, D.O., M.S.

Regulatory Operations
Chief of Project Management: Elizabeth Thompson

Office Organization

Contact Us

Mailing Address: 

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Nonprescription Drugs
10903 New Hampshire Avenue WO22 Stop 5411
Silver Spring, MD 20993
301-796-0138



Back to Top